LGND
USDLigand Pharmaceuticals Incorporated Common Stock
$189.200+1.000 (0.531%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$188.200
High
$191.455
Low
$186.280
Volume
0.47M
Company Fundamentals
Market Cap
3.7B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.23M
Exchange
NGM
Currency
USD
52-Week Range
Low $93.58Current $189.200High $194.44
Related News
Analyst Upgrades
Oppenheimer Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $250
Oppenheimer analyst Trevor Allred maintains Ligand Pharmaceuticals with a Outperform and raises the price target from $190 to $250.
View more
GlobeNewswire
Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025
JUPITER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025. The company
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.